Kana Bioconversion Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-05-2024
- Paid Up Capital ₹ 0.10 M
as on 29-05-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Kana Bioconversion Technologies
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhavanasi Siddhartha and Bhavanasi Apsara serve as directors at the Company.
- CIN/LLPIN
U74999TG2019PTC132369
- Company No.
132369
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kana Bioconversion Technologies?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bhavanasi Siddhartha | Director | 29-Apr-2019 | Current |
Bhavanasi Apsara | Additional Director | 28-Aug-2023 | Current |
Financial Performance and Corporate Structure Insights of Kana Bioconversion Technologies.
Kana Bioconversion Technologies Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Kana Bioconversion Technologies?
Unlock access to Kana Bioconversion Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ida Wellness Private Limited
Active 6 years 3 monthsBhavanasi Siddhartha and Bhavanasi Apsara are mutual person
Ira E Aqua Techno Innovations Private Limited
Active 6 years 10 daysBhavanasi Siddhartha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kana Bioconversion Technologies?
Unlock and access historical data on people associated with Kana Bioconversion Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kana Bioconversion Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kana Bioconversion Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.